If you have not told your doctor about any of the above, tell them before you start taking this medicine. Your doctor can discuss with you the risks and benefits involved. Tell your doctor if you are pregnant or plan to become pregnant or are breastfeeding.
It may affect your developing baby if you take it during pregnancy.ĭo not give this medicine to a child under the age of 1 month. swelling of the face, lips, tongue or other parts of the bodyĭo not take this medicine if you have or have had severe kidney problems.ĭo not take this medicine if you are pregnant.
Some of the symptoms of an allergic reaction may include: any of the ingredients listed at the end of this leaflet.any medicine containing nitrofurantoin or any other nitrofuran.
Before you take this medicine When you must not take itĭo not take this medicine if you have an allergy to: This medicine is only with a doctor's prescription. Your doctor may have prescribed it for another reason. It works by killing or stopping the growth of the bacteria and other organisms causing these infections.Īsk your doctor if you have any questions about why this medicine has been prescribed for you. It is an antibiotic which belongs to a group of medicines called nitrofurans. Nitrofurantoin is used to treat infections of the urinary system caused by bacteria, such as bladder infections. If you have any concerns about taking this medicine, ask your doctor or pharmacist. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. It does not take the place of talking to your doctor or pharmacist.Īll medicines have risks and benefits. It does not contain all the available information. First trimester exposure to nitrofurantoin was not associated with increased risk for total major congenital malformations or with specific malformations.Ĭongenital malformations nitrofurantoin pregnancy.This leaflet answers some common questions about this medicine.
Exposure to nitrofurantoin was not associated with increased risk of major malformations in general (adjusted OR = 0.85, 95% CI 0.67-1.08) or with specific malformations. A total of 1,329 infants and abortuses had been exposed to nitrofurantoin during the first trimester of pregnancy. Our research included a total of 105,492 pregnancies, 1,112 of which involved pregnancy terminations for medical reasons. Associations between exposure to nitrofurantoin during the first trimester and major malformations were assessed. A computerized database for medications dispensed to pregnant women in southern Israel was linked with records from the district hospital. To address these concerns, we conducted a large population-based retrospective cohort study to assess this possible association (including cases of medical terminations of pregnancy or stillbirth) and congenital malformations. While medical literature generally defines nitrofurantoin as an antibiotic that is safe for use during the first trimester of pregnancy, new concerns about a possible association between congenital malformations following exposure to nitrofurantoin during the first trimester of pregnancy have recently surfaced. Antibacterial drugs are among the most common medications used by pregnant women.